Moderna Inc (NAS:MRNA)
$ 127.535 1.865 (1.48%) Market Cap: 48.88 Bil Enterprise Value: 40.89 Bil PE Ratio: 0 PB Ratio: 3.81 GF Score: 68/100

Q2 2023 Moderna Inc Earnings Call Transcript

Aug 03, 2023 / 12:00PM GMT
Release Date Price: $109.95 (-0.24%)
Operator

Good day, and thank you for standing by. Welcome to Moderna's Second Quarter 2023 Conference Call. (Operator Instructions) Please be advised today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Lavina Talukdar, Head of Investor Relations. Please go ahead.

Lavina Talukdar
Moderna, Inc. - Senior VP & Head of IR

Thank you, Kevin. Good morning, everyone, and thank you for joining us on today's call to discuss Moderna's Second Quarter 2023 financial results and business updates. You can access the press release issued this morning as well as the slides that we'll be reviewing by going to the Investors section of our website.

On today's call are Stéphane Bancel, our Chief Executive Officer; Stephen Hoge, our President; Arpa Garay, our Chief Commercial Officer; and Jamey Mock, our Chief Financial Officer.

Before we begin, please note that this conference call will include forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot